KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Evolent Health (EVH) over the last 12 years, with Q3 2025 value amounting to -$0.24.

  • Evolent Health's EPS (Basic) rose 1111.11% to -$0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.58, marking a year-over-year decrease of 7362.64%. This contributed to the annual value of -$0.81 for FY2024, which is 3627.3% up from last year.
  • As of Q3 2025, Evolent Health's EPS (Basic) stood at -$0.24, which was up 1111.11% from -$0.44 recorded in Q2 2025.
  • Evolent Health's EPS (Basic)'s 5-year high stood at $0.02 during Q3 2022, with a 5-year trough of -$0.63 in Q1 2025.
  • Moreover, its 5-year median value for EPS (Basic) was -$0.22 (2024), whereas its average is -$0.21.
  • As far as peak fluctuations go, Evolent Health's EPS (Basic) skyrocketed by 11333.33% in 2022, and later crashed by 160000.0% in 2023.
  • Over the past 5 years, Evolent Health's EPS (Basic) (Quarter) stood at -$0.07 in 2021, then plummeted by 84.6% to -$0.12 in 2022, then crashed by 207.2% to -$0.37 in 2023, then rose by 28.25% to -$0.27 in 2024, then increased by 10.1% to -$0.24 in 2025.
  • Its EPS (Basic) stands at -$0.24 for Q3 2025, versus -$0.44 for Q2 2025 and -$0.63 for Q1 2025.